IP Library Granted Patent US 11,000,553
Granted Patent B2
US 11,000,553 · App. 16/126,656 · Granted May 11, 2021

Placental tissue composition for for treating cardiac tissue damage

Inventors: Thomas J. Koob (Marietta, GA); Hubbard Frank Burrows, III (Marietta, GA)
Assignee: MiMedx Group, Inc.
A61K35/50A61K38/1709A61K38/18A61K38/1808A61K38/1825A61K38/1841A61K38/1858A61K38/1866A61K38/2026A61K38/2066A61K38/45A61K38/57C12N5/0605C12Y207/08001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,000,553
App. No.
16/126,656
Granted
May 11, 2021
Kind
B2
Abstract

Described herein are compositions and methods of treating a cardiac condition using modified placental tissue or an extract of a placental tissue, capable of recruiting stem cells or promoting healing in vivo and in vitro.

Claims (8)

1. A composition for treating damaged cardiac tissue, said composition comprising dehydrated, cleaned, and disinfected placental tissue configured for non-obstructive placement to an area approximate to a damaged cardiac tissue in an amount sufficient to reduce damage and induce healing;

said placental tissue comprising a dehydrated amnion and a dehydrated chorion, said dehydrated amnion having an epithelial cell layer and/or a fibroblast layer; and

wherein said composition is in the form of a patch; is in an injectable form; or is micronized.

2. The composition of claim 1 , wherein the dehydrated, cleaned, and disinfected placental tissue retains an effective amount of stem cell recruiting factors, growth factors, and/or angiogenesis inducing factors.

3. The composition of claim 1 , wherein the dehydrated, cleaned, and disinfected placental tissue comprises one or more of PDGF-AA, PDGF-BB, TGFa, TGFB, bFGF, EGF, VEGF, IL-10, IL-4, P1GF, TIMP-1, TIMP-2, and TIMP-4.

4. The composition of claim 1 , which is a patch.

5. The composition of claim 1 , wherein the dehydrated, cleaned, and disinfected placental tissue is micronized.

6. The composition of claim 1 , which is in an injectable form.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066250/0132 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 046900 FRAME: 0893. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 9, 2021
From: KOOB, THOMAS J.; BURROWS, HUBBARD FRANK, III
To: MIMEDX GROUP, INC.
Reel/Frame 055955/0804 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2018
From: KOOB, THOMAS J.; BURROWS, H. FRANK, III
To: MIMEDX GROUP, INC.
Reel/Frame 046900/0893 →
Continuity (3)
Continuation 14158757 · Jan 17, 2014
Provisional Application 61849838 · Jan 18, 2013
Related Publication 20190000890A1 · Jan 3, 2019